Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates

Post time 2024-4-6 13:38:38

journal：Science Translational Medicine

Authors：Larry Zeitlin; Robert W. Cross; Courtney Woolsey; Brandyn R. West; Viktoriya Borisevich; Krystle N. Agans; Abhishek N. Prasad; Daniel J. Deer; Lauren Stuart; Maria McCavitt-Malvido; Do H. Kim; James Pettitt; James E. Crowe; Kevin J. Whaley; David Veesler; Antony Dimitrov; Dafna M. Abelson; Thomas W. Geisbert; Christopher C. Broder

Published date：2024-4-3

DOI：10.1126/scitranslmed.adl2055

PDF link：https://www.science.org/doi/pdf/10.1126/SCITRANSLMED.ADL2055

Article link：http://dx.doi.org/10.1126/scitranslmed.adl2055

Article Source：American Association for the Advancement of Science (AAAS)。

Remark：

Post time 2024-4-6 13:38:39

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2024-4-6 13:40:34

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AAAS] Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today